Creative Medical filed U.S. patent application Nos. 62,520,773 and 62,513,670 for data supporting use of immune system cells to stimulate perispinal angiogenesis (blood vessel formation) for the treatment of lower back pain, as well as support intradiscal stem cell administration to treat degenerative disc disease.
Earlier this month, the company filed a patent application covering synergy between intradiscal stem cell injections and the stimulation of angiogenesis. That filing is intended to expand on the company’s issued U.S. Patent No. 9,598,673, which addresses injection of stem cells into the lower back.
Creative Medical believes that correction of circulation abnormalities in the disc will increase the efficacy of cellular therapies for lower back pain.
Creative Medical filed U.S. patent application Nos. 62,520,773 and 62,513,670 for data supporting use of immune system cells to stimulate perispinal angiogenesis (blood vessel formation) for the treatment of lower back pain, as well as support intradiscal stem cell administration to treat degenerative disc disease.
Earlier this month, the...
Creative Medical filed U.S. patent application Nos. 62,520,773 and 62,513,670 for data supporting use of immune system cells to stimulate perispinal angiogenesis (blood vessel formation) for the treatment of lower back pain, as well as support intradiscal stem cell administration to treat degenerative disc disease.
Earlier this month, the company filed a patent application covering synergy between intradiscal stem cell injections and the stimulation of angiogenesis. That filing is intended to expand on the company’s issued U.S. Patent No. 9,598,673, which addresses injection of stem cells into the lower back.
Creative Medical believes that correction of circulation abnormalities in the disc will increase the efficacy of cellular therapies for lower back pain.
Copy to clipboard 
